Devoted Health

Backs early-stage startups working in the digital redesign of the everyday economy, usually before meaningful traction.

World's largest Black-led venture capital fund focusing on automation of the largest sectors of the Real Economy. They believe positive impact is key to profit and give back by donating 50% of our gain to create scholarships for underrepresented students.

Early-stage venture capital firm founded by entrepreneurs and operators who've built companies cumulatively worth $300 billion. GreatPoint's mission is to partner with entrepreneurs solving big problems across enterprise, healthcare, bio-tech, and food. In order to have time to fight in the trenches with every team they back, they make fewer than 10 new investments per year.

Investing in a global army of Health Transformers to achieve health moonshots.

Forged in 2015 as the private investment arm of the multi-billion dollar hedge fund, Maverick Capital, Maverick Ventures backs early-stage healthcare and technology-driven businesses through an evergreen fund structure.

Multi-stage venture fund led by Laurene Powell Jobs and focused on accelerating the growth of companies positively impacting the world

Founded by Dr. Ling Wong to fund companies using science and tech to build a better future

Focused on accelerating the growth of high-potential healthcare enterprises through value-added partnerships. Frist Cressey Invests in technology and service businesses with viable solutions that improve quality of care, system integration, patient outcomes, and population health and wellbeing.

We back ambitious founders who actively seek to change the status quo.

Early-stage, multi-thematic firm investing in purpose-driven founders reimagining the building blocks of life and society.

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio. Dr. Wong has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).

As the founding investor of a16z’s Bio Fund, Vijay leads the firm’s investments at the cross section of biology and computer science, including applications in computation, machine learning, and artificial intelligence in healthcare; digital therapeutics; diagnostics; and other novel transformative scientific advances applied to industry that take bio beyond healthcare.

Vishal invests in values-driven founders and companies that dramatically improve healthcare outcomes, create more human-centered financial systems, and reimagine consumer services from the ground up. He leads Obvious’ investments in full-stack healthcare with Virta, Galileo, and Devoted Health; financial technology startups such as Hedvig, One, Corvus, and Openly; and purpose-led consumer services like Good Eggs and Block Renovation. Before co-founding Obvious, Vishal was the founding partner of Indian-based fund SONG Investment Advisors. He also served as a senior executive at Steve Case’s Revolution, LLC. Prior to his career as an investor, Vishal spent a decade at outdoor gear and apparel retailer Patagonia, in roles ranging from product manager to Chief Strategy Officer. He was selected as a Henry Crown Fellow of the Aspen Institute and a Next Generation Fellow of the American Assembly, both recognizing value-based leadership.